Document:

Exhibit
          10.2 L.Siebert Employment Agreement

         

          

            EMPLOYMENT
              AGREEMENT

             

            This
              Employment Agreement (the “Agreement”) is entered into as of this 15th day of
              June, 2006 by and between Chembio Diagnostics, Inc., a Nevada corporation
              (the
“Company”), and Lawrence A. Siebert (“Employee”) and to be effective as of May
              10, 2006 (the “Effective Date”). Employee and the Company are sometimes referred
              to individually as a “Party” and collectively as the “Parties.”

             

            In
              consideration of the mutual covenants, promises and agreements herein
              contained,
              the Company and Employee hereby covenant, promise and agree to and
              with each
              other as follows:

             

             

            1. Employment.
              The
              Company shall employ Employee and Employee shall perform services for
              and on
              behalf of the Company upon the terms and conditions set forth in this
              Agreement.

             

             

            2. Positions
              and Duties of Employment.
              Employee shall be required to devote his full energy, skill and best
              efforts as
              required to the furtherance of his managerial duties with the Company
              as the
              Company’s President and Chief Executive Officer. While serving in such
              capacities, Employee shall have the responsibilities, duties, obligations,
              rights, benefits and requisite authority as is customary for his position
              and as
              may be determined by the Company’s Board of Directors (the
“Board”).

             

            Employee
              understands that his employment as President and Chief Executive Officer
              of the
              Company involves a high degree of trust and confidence, that he is
              employed for
              the purpose of furthering the Company’s reputation and improving the Company’s
              operations and profitability, and that in executing this Agreement
              he undertakes
              the obligations set forth herein to accomplish such objectives. Employee
              agrees
              that he shall serve the Company fully, diligently, competently and
              to the best
              of his ability. Employee certifies that he fully understands his right
              to
              discuss this Agreement with his attorney, that he has availed himself
              of this
              right to the extent that he desires, that he has carefully read and
              fully
              understands this entire Agreement, and that he is voluntarily entering
              into this
              Agreement.

             

            3. Duties.
              Employee shall perform the following services for the Company:

             

             

            (a) Employee
              shall serve as President and Chief Executive Officer of the Company,
              or in such
              other position as determined by the Board, and in those capacities
              shall work
              with the Company to pursue the Company’s plans as directed by the
              Board.

             

             

            (b) Employee
              shall perform duties with the functions of an officer of the Company,
              subject to
              the direction of the Board.

             

             

            (c) During
              the Term of this Agreement (defined below), Employee shall devote substantially
              all of Employee’s business time to the performance of Employee’s duties under
              this Agreement. Without limiting the foregoing, Employee shall perform
              services
              on behalf of the Company for at least forty hours per week, and Employee
              shall
              be available at the request of the Company at other times, including
              weekends
              and holidays, to meet the needs and requests of the Company’s
              customers.

             

            
              
                1

              

              
                
                

                
                  

                

              

              
                
                

              

            

            (d) During
              the Term, Employee will not engage in any other activities or undertake
              any
              other commitments that conflict with or take priority over Employee’s
              responsibilities and obligations to the Company and the Company’s customers,
              including without limitation those responsibilities and obligations
              incurred
              pursuant to this Agreement.

             

             

            4. Term.
              Unless
              terminated earlier as provided for in this Agreement, the term of this
              Agreement
              shall be for two years, commencing on the Effective Date and ending
              on the
              second anniversary of the Effective Date (the “Term”). If the employment
              relationship is terminated by either Party, Employee agrees to cooperate
              with
              the Company and with the Company’s new management with respect to the transition
              of the new management in the operations previously performed by Employee.
              Upon
              Employee’s termination, Employee agrees to return to the Company all Company
              documents (and all copies thereof), any other Company property in Employee’s
              possession or control, and any materials of any kind that contain or
              embody any
              proprietary or confidential material of the Company. 

             

             

            5. Compensation.
              Employee shall receive the following as compensation:

             

             

            (a) A
              base
              salary at an annual rate of $240,000, subject to periodic review by
              the Board or
              the Compensation Committee of the Board (the “Committee”), payable in accordance
              with the Company’s customary payroll practices (the “Base Salary”). At the
              commencement of the second year following the Effective Date, the Board
              or the
              Committee shall review the Base Salary, and shall consider a potential
              increase
              in the Base Salary for the remainder of the Term. Any determination
              made by the
              Board or the Committee will be made in the Board’s or the Committee’s sole and
              absolute discretion.

             

            (b) A
              performance-based bonus of up to 50% of the Base Salary, to be comprised
              of:

             

             

            (i) A
              performance-based bonus of up to 25% of the Base Salary in accordance
              with
              revenue and profit (loss) criteria established each year by the Board;
              and

             

            (ii) In
              the
              sole and
              absolute discretion
              of the Board or the Committee, a discretionary bonus of up to 25% of
              the Base
              Salary. 

             

             

            (c) If
              Employee is eligible, the Company shall include Employee in any profit
              sharing
              plan, executive stock option plan, pension plan, retirement plan, medical
              and/or
              hospitalization plan, and/or any and all other benefit plans, except
              for
              disability and life insurance, which may be placed in effect by the
              Company for
              the benefit of the Company executives during the Term. Except for the
              fact that
              the Company at all times shall provide Employee with all or at least
              a portion
              of Employee’s medical and/or hospitalization insurance, which shall not be less
              than that afforded to the Company’s other executives, nothing in this Agreement
              shall limit (i) the Company’s ability to exercise the discretion provided to it
              under any such benefit plan, or (ii) the Company’s discretion to adopt, not
              adopt, amend or terminate any such benefit plan at any time.

             

            
              
                2

              

              
                
                

                
                  

                

              

              
                
                

              

            

            (d) Employee
              shall be entitled to six weeks vacation leave for each year of the
              Term, as well
              as sick leave, medical insurance coverage and any other benefits consistent
              with
              the Company’s plans and policies in effect for the Company’s executives from
              time to time. The Company may modify in its sole and absolute discretion
              such
              benefits from time to time as it considers necessary or
              appropriate.

             

             

            (e) During
              the Term, Employee shall be reimbursed for reasonable expenses that
              are
              authorized by the Company and that are incurred by Employee for the
              benefit of
              the Company in accordance with the standard reimbursement practices
              of the
              Company. Any direct payment or reimbursement of expenses shall be made
              only upon
              presentation of an itemized accounting conforming in form and content
              to
              standards prescribed by the Internal Revenue Service relative to the
              substantiation of the deductibility of business expenses. 

             

             

            (f) The
              Company shall reimburse Employee for all expenses Employee incurs in
              connection
              with his use of a cellular telephone for Company purposes.

             

            (g) In
              addition to the Base Salary, during the Term the Company shall provide
              Employee
              $600.00 per month, as compensation for Employee’s cost of ownership of a vehicle
              to be used for Company purposes. In addition, the Company shall reimburse
              Employee for maintenance expenses Employee incurs in connection with
              his use of
              a vehicle for Company purposes.

             

             

            (h) Any
              payments which the Company shall make to Employee pursuant to this
              Agreement
              shall be reduced by standard withholding and other applicable payroll
              deductions, including, without limitation, federal, state or local
              income or
              other taxes, social security and medicare taxes, state unemployment
              insurance
              deductions, state disability insurance deductions, and any other applicable
              tax
              or deduction (collectively, any withheld taxes and deductions,
“Deductions”).

             

            

            6. Confidentiality.
              

             

             

            (a) Employee
              hereby warrants, covenants and agrees that, without the prior express
              written
              consent of the Company, and unless required by law, court order or
              similar
              process, Employee shall hold in the strictest confidence, and shall
              not disclose
              to any person, firm, corporation or other entity, any and all of the
              Company’s
              information, including, for example, and without limitation, any data
              related to
              (i) drawings, sketches, plans or other documents concerning the Company’s
              business or development plans, customers or suppliers; (ii) the Company’s
              development, design, construction or sales and marketing methods or
              techniques;
              or (iii) the Company’s trade secrets and other “know-how” or information not of
              a public nature, regardless of how such information came to the custody
              of
              Employee (collectively, subsections (i), (ii) and (iii) of this section
              6(a),
“Information”). For purposes of this Agreement, such Information shall include,
              but not be limited to, any information regarding a formula, pattern,
              compilation, program, device, method, technique or process that (A)
              derives
              independent economic value, present or potential, not being generally
              known to,
              and not being readily ascertainable by proper means by, other persons
              who can
              obtain economic value from its disclosure or use, and (B) is the subject
              of
              Company efforts. 

             

            
              
                3

              

              
                
                

                
                  

                

              

              
                
                

              

            

             

            (b) In
              the
              event Employee is required by law, court order or similar process to
              disclose
              any Information, Employee shall provide immediate notice of such obligatory
              disclosure prior to such disclosure, so that the Company, at its sole
              option,
              may attempt to seek a protective order or other appropriate remedy
              to preclude
              such disclosure.

             

             

            (c) The
              warranty, covenant and agreement set forth in this section 6 shall
              not expire,
              shall survive this Agreement, and shall be binding upon Employee without
              regard
              to the passage of time or any other event.

             

             

            7. Non-Compete.
              Employee acknowledges and recognizes the highly competitive nature
              of the
              Company’s business and that Employee’s duties hereunder justify restricting
              Employee’s further employment following any termination of employment. Employee
              agrees that so long as Employee is employed by the Company, and for
              a period of
              two years following the termination of this Agreement, Employee, except
              when
              acting at the request of the Company on behalf of or for the benefit
              of the
              Company, shall not induce customers, agents or other sources of distribution
              of
              the Company’s business under contract or doing business with the Company to
              terminate, reduce, alter or divert business with or from the
              Company.

             

             

            8. Termination.
              

             

             

            (a) If
              Employee’s employment is terminated by the Company without Cause (defined
              below), or if Employee terminates his employment for Reasonable Basis
              (defined
              below), then the Company shall, in exchange for Employee’s execution of a
              general release and waiver of claims against the Company as of the
              termination
              date in a form reasonably acceptable to the Company, continue to pay
              as
              severance Employee’s Base Salary for a period of six months following the date
              such general release and waiver of claims is executed. Such payments
              shall be
              made in accordance with the Company’s customary payroll practices, and shall be
              subject to all applicable Deductions. In the event of any such termination
              set
              forth in this section 8(a), Employee will not be entitled to any additional
              compensation or benefits beyond what is provided in the first sentence
              of this
              section 8(a).

             

             

            (i) For
              purposes of this Agreement, “Cause” shall mean that the Board, acting in good
              faith based upon the information then known to the Company, determines
              that
              Employee has engaged in or committed any of the following: (A) willful
              misconduct, gross negligence, theft, fraud, or other illegal conduct;
              (B)
              refusal or unwillingness to perform Employee’s duties; (C) performance by
              Employee of Employee’s duties determined by the Board to be inadequate in a
              material respect; (D) breach of any applicable non-competition provision,
              confidentiality provision or other proprietary information or inventions
              agreement between Employee and the Company; (E) inappropriate conflict
              of
              interest; (F) insubordination; (G) failure to follow the directions
              of the Board
              or any committee thereof; (H) any other material breach of this Agreement.
              In
              addition, an indictment or conviction of any felony, or any entry of
              a plea of
              nolo contendre, under the laws of the United States or any State shall
              be
              considered “Cause” hereunder. “Cause” shall be specified in a notice of
              termination to be delivered by the Company to Employee no later than
              the date as
              of which termination is effective.

             

            
              
                4

              

              
                
                

                
                  

                

              

              
                
                

              

            

             

            (ii) For
              purposes of this Agreement, “Reasonable Basis” shall mean (A) a material breach
              of this Agreement by the Company, provided, however, that Employee
              shall provide
              written notice to the Company of any alleged material breach, and any
              alleged
              material breach will only be considered a material breach if the Company
              fails
              to cure such breach within thirty days after receiving notice of such
              breach;
              (B) termination of Employee’s employment by the Company without Cause during the
              term hereof; (C) a reduction in Employee’s salary, except to the extent that a
              majority of the other executive officers of the Company incur reductions
              of
              salary that average no less than the percentage reduction incurred
              by Employee;
              or (D) termination of Employee’s employment by Employee within twelve months
              after a “Change Of Control,” which is defined as any of the
              following:

             

            (1) any
              consolidation or merger of the Company in which the Company is not
              the
              continuing or surviving corporation, other than a merger of the Company
              in which
              the holders of the Company’s voting common stock immediately prior to the merger
              own a majority of the voting common stock of the surviving corporation
              immediately after the merger;

             

            (2) any
              sale,
              lease, exchange or other transfer (in one transaction or a series of
              related
              transactions) of all or substantially all the assets of the
              Company;

             

            (3) any
              approval by the stockholders of the Company of any plan or proposal
              for the
              liquidation or dissolution of the Company;

             

            (4) the
              acquisition by any person or entity, or any group of persons and/or
              entities of
              a majority of the stock entitled to elect a majority of the directors
              of the
              Company; or

             

            (5) subject
              to applicable law, in a Chapter 11 bankruptcy proceeding, the appointment
              of a
              trustee or the conversion of a case involving the Company to a case
              under a
              Chapter 7 bankruptcy proceeding.

             

             

            (b) In
              the
              event that Employee’s employment with the Company is terminated for Cause, by
              reason of Employee’s death or disability, or due to Employee’s resignation or
              voluntary termination (other than for a Reasonable Basis), then all
              compensation
              and benefits will cease as of the effective date of such termination,
              and
              Employee shall receive no severance benefits, or any other compensation;
              provided that Employee shall be entitled to receive all compensation
              earned and
              all benefits and reimbursements due through the effective date of
              termination.

             

            
              
                5

              

              
                
                

                
                  

                

              

              
                
                

              

            

             

            (c) Employee
              agrees that the payments contemplated by this Agreement shall constitute
              the
              exclusive and sole remedy for any termination of employment, and Employee
              covenants not to assert or pursue any other remedies, at law or in
              equity, with
              respect to any termination of employment. 

             

             

            (d) Any
              Party
              terminating this Agreement shall give prompt written notice to the
              other Party
              hereto advising such other Party of the termination of this Agreement
              stating in
              reasonable detail the basis for such termination (the “Notice of Termination”).
              The Notice of Termination shall indicate whether termination is being
              made for
              Cause (if the Company has terminated the Agreement) or for a Reasonable
              Basis
              (if Employee has terminated the Agreement).

             

             

            9. Remedies.
              If
              there is a breach or threatened breach of any provision of Section
              6 or Section
              7 of this Agreement, the Company will suffer irreparable harm and shall
              be
              entitled to an injunction restraining Employee from such breach. Nothing
              herein
              shall be construed as prohibiting the Company from pursuing any other
              remedies
              for such breach or threatened breach.

             

             

            10. Severability.
              It is
              the clear intention of the Parties to this Agreement that no term,
              provision or
              clause of this Agreement shall be deemed to be invalid, illegal or
              unenforceable
              in any respect, unless such term, provision or clause cannot be otherwise
              construed, interpreted, or modified to give effect to the intent of
              the Parties
              and to be valid, legal or enforceable. The Parties specifically charge
              the trier
              of fact to give effect to the intent of the Parties, even if in doing
              so,
              invalidation of a specific provision of this Agreement is required
              to make the
              Agreement consistent with the foregoing stated intent. In the event
              that a term,
              provision, or clause cannot be so construed, interpreted or modified,
              the
              validity, legality and enforceability of the remaining provisions contained
              herein and other application(s) thereof shall not in any way be affected
              or
              impaired thereby and shall remain in full force and effect.

             

             

            11. Waiver
              of Breach.
              The
              waiver by the Company or Employee of the breach of any provision of
              this
              Agreement by the other Party shall not operate or be construed as a
              waiver of
              any subsequent breach by that Party. 

             

             

            12. Entire
              Agreement.
              This
              document contains the entire agreement between the Parties and supersedes
              all
              prior oral or written agreements, if any, concerning the subject matter
              hereof
              or otherwise concerning Employee’s employment by the Company (except for options
              to purchase shares of the Company’s restricted stock previously granted to
              Employee). This Agreement may not be changed orally, but only by a
              written
              agreement signed by both Parties.

             

             

            13. Governing
              Law.
              This
              Agreement, its validity, interpretation and enforcement, shall be governed
              by
              the laws of the State of New York, excluding conflict of laws principles.
              Employee hereby expressly consents to personal jurisdiction in the
              state and
              federal courts located in Long Island, NY for any lawsuit filed there
              against
              him by the Company arising from or relating to this Agreement.

             

            
              
                6

              

              
                
                

                
                  

                

              

              
                
                

              

            

             

            14. Notices.
              Any
              notice pursuant to this Agreement shall be validly given or served
              if that
              notice is made in writing and delivered personally or sent by certified
              mail or
              registered, return receipt requested, postage prepaid, to the following
              addresses:

             

            If
              to
              Company:  Chembio
              Diagnostics, Inc.

            3661
              Horseblock Road, Suite A

            Medford,
              NY 11763

            Attention:
              CFO

             

            If
              to
              Employee: To
              the
              address for Employee set forth below his signature.

             

            All
              notices so given shall be deemed effective upon personal delivery or,
              if sent by
              certified or registered mail, five business days after date of mailing.
              Either
              Party, by notice so given, may change the address to which his or its
              future
              notices shall be sent.

             

             

            15. Assignment
              and Binding Effect.
              This
              Agreement shall be binding upon Employee and the Company and shall
              benefit the
              Company and its successors and assigns. This Agreement shall not be
              assignable
              by Employee.

             

             

            16. Headings.
              The
              headings in this Agreement are for convenience only; they form no part
              of this
              Agreement and shall not affect its interpretation.

             

             

            17. Construction.
              Employee represents he has (a) read and completely understands this
              Agreement
              and (b) had an opportunity to consult with such legal and other advisers
              as he
              has desired in connection with this Agreement. This Agreement shall
              not be
              construed against any one of the Parties.

             

            18. Insurance.
              The
              Company is to maintain directors’ and officers’ insurance in an amount
              reasonably determined by the Board.

             

            
              
                7

              

              
                
                

                
                  

                

              

              
                
                

              

            

            IN
              WITNESS WHEREOF, the Parties have caused this Agreement to be executed
              the day
              and year first above written.

             

            EMPLOYEE                                 COMPANY

             

            Lawrence
              A. Siebert                             Chembio
              Diagnostics, Inc. 

             

                                        By:                

            Lawrence
              A. Siebert                              Richard
              Larkin

            75
              Shady
              Knoll Drive                            Chief
              Financial Officer

            Stamford,
              CT 06903 

            

            

            

            *
              * * *
              *================================================================================

                              SETTLEMENT AGREEMENT
                                       AND
                                 MUTUAL RELEASE

         This agreement is made and entered into this 10th day of February,
2006, by and between Howard Salamon d/b/a Salamon Brothers ("Salamon") and
CirTran Corporation ("CirTran").

                                    Recitals

         A.       Salamon is an individual who does business in his own name and
under the name "Salamon Brothers."

         B.       CirTran is a Nevada corporation. CirTran maintains its
principal place of business in Utah.

         C.       On February 26, 2003, Salamon filed a complaint against
CirTran in the United States District Court, Eastern District of New York,
entitled "Howard Salamon d/b/a Salamon Brothers, Plaintiff, vs. CirTran
Corporation, Defendant," case no. 2:03-cv-00948-JS-ARL. On April 7, 2003,
CirTran filed a motion objecting to the jurisdiction of the Eastern District of
New York. On May 9, 2003, Salamon voluntarily dismissed the lawsuit in the
Eastern District of New York

         D.       On September 11, 2003, Salamon re-filed the lawsuit in the
United States District Court for the District of Utah, Central Division, case
no. 2:03-cv-00787-TS-SA. The Complaint asserts claims for Specific Performance
and Breach of Contract seeking to recover a fee to be paid in the form of
restricted shares of CirTran common stock that allegedly became due on November
5, 2002, based on a $5 million equities financing transaction that occurred
between CirTran and third-party Cornell Capital Partners L.P. ("Cornell") on
that date.

         E.       On October 10, 2003, CirTran filed an Answer to the Complaint
denying the material allegations thereof and asserting various affirmative
defenses.

         F.       On December 13, 2004, Salamon filed a Supplemental Complaint
in the District of Utah in which he added claims for Specific Performance and
Breach of Contract seeking to recover an additional fee from a second equities
financing transaction that occurred between CirTran and Cornell on May 12, 2004.

         G.       On January 26, 2005, CirTran filed an Answer to the
Supplemental Complaint denying the material allegations of the Supplemental
Complaint and asserting various affirmative defenses.

         H.       The claims asserted in the Complaint and Supplemental
Complaint allege that CirTran is obligated to pay Salamon these fees pursuant to
a Financial Consulting Agreement dated October 2, 2002. Salamon alleges that his
fees became due and owing on the date of each of CirTran's transactions with
Cornell, as recited above, and that CirTran has failed to pay the fee by

                                       1
<PAGE>

issuance of the restricted shares of CirTran common stock required by the
parties' contracts.

         I.       The parties hereto disagree whether and to what extent CirTran
is liable to Salamon for the claims asserted in the Complaint and Supplemental
Complaint. Nevertheless, the parties have agreed to a settlement of the claims
asserted in these actions on the terms stated herein.

         NOW THEREFORE, pursuant to these Recitals, and for and in consideration
of the terms and conditions of this agreement, the mutual benefits to be derived
herefrom, and other good and valuable consideration, the parties agree as
follows:

         1.       Shares of Common Stock.

                  a.       Issuance of CirTran Stock. Not later than four (4)
business days following the execution of this agreement by all of the parties
hereto, CirTran shall deliver to Salamon a certificate (the "Certificate")
representing four million (4,000,000) shares (the "Shares") of CirTran common
stock. This Certificate will bear the restrictive legend required by Rule 144.

                  b.       Removal of the Restrictive Legend. Upon tender by
Salamon to CirTran or its counsel of (i) the Certificate signed by Salamon, and
(ii) the Rule 144(k) Representations in the form attached hereto as Exhibit A,
CirTran shall cause its counsel to deliver an opinion to CirTran's transfer
agent, with a copy to Salamon, stating that the restrictive legend on the
Certificate may be removed, which opinion shall be issued within two (2)
business days after receipt of the signed Certificate and Rule 144(k)
Representations. CirTran shall immediately thereafter cause its transfer agent
to cancel the Certificate bearing the restrictive legend and issue to Salamon a
new certificate representing the Shares without a restrictive legend.

                  c.       Ownership of Shares. CirTran hereby acknowledges that
it is issuing these Shares in connection with this settlement as payment of
Salamon's fee, that this fee was earned by Salamon on November 5, 2002, the date
on which CirTran closed an equity financing transaction with Cornell, that the
Company should have paid this fee on that date, and that Salamon was entitled to
receive the fee as of that date.

         2.       Warrants to Purchase Common Stock.

                  a.       Issuance of Warrants. Not later than five (5)
business days following the execution of this agreement by all of the parties
hereto, CirTran shall deliver the following to Salamon:

                           i.       A Warrant for Howard Salamon to purchase
         5,250,000 shares of CirTran common stock at a strike price of five
         cents per share that shall remain open for 5 years following the date
         of issuance of the Warrant. This Warrant shall be in the form attached
         hereto as Exhibit B.

                                       2
<PAGE>

                           ii.      A Warrant for Melissa A. Cohen to purchase
         1,750,000 shares of CirTran common stock at a strike price of five
         cents per share that shall remain open for 5 years following the date
         of issuance of the Warrant. This Warrant shall be in the form attached
         hereto as Exhibit C.

                  b.       Piggy-Back Registration Rights. Not later than 6
months following the date of execution of this agreement by all of the parties
hereto, CirTran shall prepare and file with the U.S. Securities and Exchange
Commission ("SEC") a registration statement (the "Registration Statement") and
shall include in the Registration Statement the resale by the Holders (as that
term is defined in the Warrants attached hereto) of the shares of common stock
(the "Underlying Shares") issuable upon exercise of the Warrants. CirTran shall
use its best efforts to have the Registration Statement declared effective by
the SEC, and Salamon shall cooperate and assist CirTran by providing whatever
information may be necessary or requested by the SEC. CirTran does not represent
or warrant that the Registration Statement will be declared effective or that
the SEC will allow it to remain effective for any period of time. CirTran shall
send a copy of the Registration Statement to Salamon when it is filed with the
SEC.

                  c.       Investment Representations and Warranties. Because
the issuance of the Warrants by the CirTran to Salamon constitutes a transaction
in securities, to further induce CirTran's issuance of the Warrants, Salamon
hereby represents and warrants to CirTran and its agents and attorneys as
follows:

                           i.       Accredited Status. Salamon is an "Accredited
                  Investor" as that term is defined in Regulation D under the
                  Securities Act.

                           ii.      Sole Party in Interest. Salamon is the sole
                  and true party in interest, and no person or entity other than
                  Salamon and Melissa A. Cohen have or will have upon the
                  issuance of the Warrants any beneficial ownership interest in
                  the Warrants or any portion of the Warrants, whether direct or
                  indirect.

                           iii.     Investment Purpose. Salamon represents that
                  he is acquiring the Warrants for his own account for
                  investment purposes and not on behalf of any other person or
                  entity or for or with a view to resale or distribution.

                           iv.      Knowledge and Experience. Salamon has been
                  advised, to his satisfaction and understanding, with respect
                  to the advisability of an investment in CirTran. Salamon is
                  experienced in evaluating and making speculative investments,
                  and has the capacity to protect his interests in connection
                  with the acquisition of the Warrants and any share issued
                  thereunder. Salamon has such knowledge and experience in
                  financial and business matters in general, and investments in
                  the manufacturing industry in particular, that Salamon is
                  capable of evaluating the merits and risks of Salamon's
                  investment in CirTran. Salamon has been informed that an
                  investment in CirTran is speculative and has concluded that

                                       3
<PAGE>

                  Salamon's proposed investment is appropriate in light of his
                  overall investment objectives and financial situation.

                           v.       Investment Advisors. Salamon represents that
                  no investment advisor or Salamon representative has been
                  consulted or retained in connection with Salamon's decision to
                  obtain the Warrants.

                           vi.      Exclusive Reliance on this Agreement. In
                  making the decision to obtain the Warrants, Salamon has relied
                  exclusively upon information included in this Agreement, and
                  investigations made by Salamon, and not on any other
                  representations, promises or information, whether written or
                  verbal, by any person.

                           vii.     Accuracy of Representations and Information.
                  All representations made by Salamon in this Agreement and all
                  documents and instruments related to this Agreement, and all
                  information provided by Salamon to CirTran concerning Salamon
                  and his respective financial positions is correct and complete
                  as of the date hereof. If there is any material change in such
                  information before the actual issuance of the Warrants,
                  Salamon immediately will provide such information to CirTran.
                  Salamon specifically acknowledges that CirTran will rely on
                  these representations contained in this Section 2.c. in
                  connection with CirTran's ability to issue the Warrants.

                           viii.    No Representations. None of the following
                  have ever been represented, guaranteed, or warranted to
                  Salamon or Melissa A. Cohen by CirTran or any of its
                  employees, agents, representatives or affiliates, or any
                  broker or any other person, including Salamon, expressly or by
                  implication:

                                    (a) The approximate or exact length of time
                                    that Salamon or Melissa A. Cohen will be
                                    required to remain as owner of the Shares
                                    and the Warrants;

                                    (b) The percentage of profit or amount of or
                                    type of consideration, profit or loss
                                    (including tax write-offs or other tax
                                    benefits) to be realized, if any, as a
                                    result of an investment in the Shares and
                                    the Warrants; or

                                    (c) The past performance or experience on
                                    the part of the Company or any affiliate or
                                    their associates, agents or employees, or of
                                    any other person as being indicative of
                                    future results of an investment in the
                                    Shares and the Warrants.

         3.       Release by Salamon. In exchange for this agreement, Salamon
and his agents, successors and assigns, hereby irrevocably and unconditionally
release and forever discharge CirTran, its successors, assigns, officers,
directors, owners, employees, insurers, agents, representatives, and attorneys,

                                       4
<PAGE>

and all persons acting by, through, under or in concert with them, or any of
them, including Iehab Hawatmeh, from any and all actions, causes of action,
suits, claims, rights, damages, losses, costs and expenses (including attorneys'
fees and costs actually incurred) of any nature whatsoever, known or unknown,
suspected or unsuspected, fixed or contingent which he now has, owns or holds,
or claims to have, own or hold, or at any time heretofore had, owned or held, or
claimed to have, own or hold, or may hereafter have, own or hold, or claim to
have, own or hold, arising out of conduct or matters occurring prior to the date
of this agreement.

         It is the intention of the parties that CirTran shall have no further
obligation to Salamon. CirTran is free to engage in financing arrangements of
its choosing with any party of its choosing without incurring any obligation to
pay a fee to Salamon or give him some other consideration. Salamon hereby
acknowledges that all obligations owed by CirTran pursuant to any contract he
has or may have had with CirTran, including but not limited to the Financial
Consulting Agreement dated September 20, 2001, and the Letter of Agreement dated
October 2, 2002, are by this agreement irrevocably and unconditionally
discharged and satisfied in full.

         4.       Release by CirTran. In exchange for this agreement, CirTran
and its officers, agents, successors and assigns, hereby irrevocably and
unconditionally release and forever discharge Salamon and his insurers, agents,
representatives, and attorneys, and all persons acting by, through, under or in
concert with them, or any of them, from any and all actions, causes of action,
suits, claims, rights, damages, losses, costs and expenses (including attorneys'
fees and costs actually incurred) of any nature whatsoever, known or unknown,
suspected or unsuspected, fixed or contingent which they now have, own or hold,
or claim to have, own or hold, or at any time heretofore had, owned or held, or
claimed to have, own or hold, or may hereafter have, own or hold, or claim to
have, own or hold, arising out of conduct or matters occurring prior to the date
of this agreement.

         5.       Dismissal of Action. Concurrent with the execution of this
agreement by all of the parties hereto, the parties will execute, through their
respective attorneys, and file with the United States District Court a Request
for Dismissal and proposed Order of Dismissal, in the form attached hereto as
Exhibit D, requesting that the court dismiss the Complaint and Supplemental
Complaint with prejudice with each party to bear its own attorneys' fees and
costs. By executing this Settlement Agreement, the parties each hereby authorize
and instruct their respective attorneys to execute and file the Request for
Dismissal and proposed Order of Dismissal attached hereto.

         6.       Notices and Delivery. Any notice to be given to any party
shall be served by U.S. Mail, certified, return receipt requested, and shall be
deemed complete on the date the notice is received by the recipient as indicated
on the return receipt. The deliveries required under paragraphs 1 and 2, above,
shall be done by Federal Express next business day delivery with a tracking
number. Deliveries and notice shall be given as follows, unless written notice
of change of address is given to all parties:

                                       5
<PAGE>

         If to Salamon:

                  Howard Salamon
                  20 Margaret Avenue
                  Lawrence, New York  11559
                  (516) 371-9440

                  with a copy to:

                  Eric W. Berry, Esq.
                  Eric W. Berry PC
                  132 Nassau Street, Suite 1310
                  New York, New York 10038

         If to CirTran:

                  CirTran Corporation
                  Attn:  Iehab Hawatmeh
                  4125 South 6000 West
                  West Valley City, Utah  84128

                  with a copy to:

                  David W. Tufts, Esq.
                  Durham Jones & Pinegar
                  111 East Broadway, Suite 900
                  P.O. Box 4050
                  Salt Lake City, Utah  84111-4050

         7.       Consideration. The parties hereto acknowledge and agree that
good and valuable consideration has been given for the covenants and agreements
set forth herein and that each party has been fully advised (to the extent that
they have deemed necessary) regarding this agreement and their respective claims
by competent legal counsel of their choosing.

         8.       No Admission of Liability. The parties agree that this
agreement is entered into in settlement of disputed claims, and execution of
this agreement shall not be deemed to be an admission of liability or an
admission against interest by any party hereto.

         9.       Non-assignment. The parties each warrant and represent that
there has been no assignment, sale, or transfer of any of the claims being
released hereby and that their execution of this agreement constitutes a full
and complete release and discharge of those claims. The parties each warrant and
represent that there has been no prior assignment of the assets being
transferred hereunder.

                                       6
<PAGE>

         10.      Full and Independent Knowledge. Each party hereto represents
that it has been represented by an attorney in connection with the preparation
and review of this agreement, that its representative has specifically discussed
with its attorney the meaning and effect of this agreement and that its
representative has carefully read and understands the scope and effect of each
provision contained herein. Each party hereto further represents that it does
not rely and has not relied upon any representation or statement made by the
other party hereto or any of its representatives with regard to the subject
matter, basis or effect of this agreement and has voluntarily entered into this
agreement.

         11.      Successors. This agreement shall be binding upon and inure to
the benefit of the administrators, successors and assigns of each of the
parties.

         12.      Preparation of This Agreement and Construction of its Terms.
The parties agree that each of them have, through their attorneys, participated
in and contributed to the preparation of this agreement. The parties agree that
this agreement shall be regarded and deemed as having been prepared jointly by
the parties hereto. Any ambiguity or uncertainty existing herein shall not be
interpreted or construed against any party thereto by virtue of who may have
drafted such provision.

         13.      Amendment to This Agreement. This agreement may not be
altered, amended, modified or otherwise changed in any respect or particular
whatsoever except by a writing executed by an authorized representative of each
party hereto.

         14.      Further Assurances. Each of the parties, without further
consideration, agrees to execute and deliver such other documents and take such
other action as may be necessary to consummate more effectively the subject
matter hereof.

         15.      Authorization. Any person signing this agreement for or on
behalf of an entity other than a natural person does by said signature warrant
that he or she is duly authorized by said entity to undertake such action on its
behalf, and that such signature is the valid and binding act of that entity.

         16.      Attorneys' Fees. If any action is brought because of any
breach of or to enforce, interpret, rescind, or terminate any of the provisions
of this agreement, the party prevailing in such action shall be entitled to
recover from the other party reasonable attorneys' fees and court costs incurred
in connection with such action, the amount of which shall be fixed by the court
and made a part of any judgment rendered.

         17.      Entire Agreement. This agreement sets forth the entire
agreement between the parties and supersedes any and all prior contracts,
agreements or understandings between the parties pertaining to the subject
matter hereof.

                                       7
<PAGE>

         IN WITNESS WHEREOF, the parties have executed this Settlement Agreement
and Mutual Release as of the date first shown above.

         CirTran:                           CIRTRAN CORPORATION

                                            By:   /s/ Iehab Hawatmeh
                                                -------------------------------
                                                 Iehab Hawatmeh, President

         Salamon:
                                                 /s/ Howard Salamon
                                                -------------------------------
                                                 Howard Salamon, an individual,
                                                 d/b/a Salamon Brothers

                                       8
<PAGE>

                                    EXHIBIT A

<PAGE>

Rule 144(k) Representations
---------------------------
To CirTran Corporation

Re:      Removal of Restrictive Legend Pursuant to Rule 144(k)

         Howard Salamon
         20 Margaret Avenue
         Lawrence, New York  11559
         (516) 371-9440

Total Number of Shares:  4,000,000    Certificate Number _________________

Gentlemen:

         This letter is submitted to the Company in connection with my request
that the restrictive legend on the certificate(s) representing the above
identified securities (the "Securities") be removed pursuant to Rule 144
promulgated under the Securiteis Act of 1933 ("Rule 144"). In connection
herewith, the undersigned represents and warrants to the Company as follows:

1.       The undersigned is not and has not during the preceding three months of
         the date of this letter been an affiliate of the Company, within the
         meaning of Rule 144(a)(1), (i.e. a person that directly or indirectly,
         through one or more intermediaries, control or is controlled by or is
         under common control with the Company.)
2.       The Securities are "restricted securities" as defined in Rule
         144(a)(3).
3.       I have been the beneficial owner of the Securities for more than the
         past two years. Neither I nor any "related persons" have had a short
         position in, or any put or option to dispose of, any of the securities
         of the Company or any securities convertible into such securities of
         the same class at any time; and the full purchase price for the
         Securities was paid more than two years ago.
4.       I understand that Rule 144(k) prohibits sales made by a person who is
         an affiliate at the time of sale or by a person who was an affiliate of
         the Company during the 3 months preceding the sale. Thus, while the
         Company may remove the restricted legend from the certificate(s)
         representing my securities based upon the facts as they exist on the
         date of this letter, any change in my status may require the Company to
         reissue certificates to me with a restricted legend placed thereon.
5.       I further agree to notify the Company promptly of any changes in the
         facts set forth in this letter.
6.       I have not agreed to act in concert with any other person for the
         purpose of selling securities of the Company.

To the best of my knowledge and belief, all of the foregoing information is
accurate and complete as of the date hereof.

     Sincerely,

     ________________________________________ Date ________________________
         Howard Salamon

<PAGE>

                                    EXHIBIT B

<PAGE>

                                     WARRANT
                                     -------

THE SECURITIES  REPRESENTED BY THIS WARRANT HAVE NOT BEEN  REGISTERED  UNDER THE
SECURITIES ACT OF 1933, AS AMENDED,  OR APPLICABLE  STATE  SECURITIES  LAWS. THE
SECURITIES  HAVE BEEN ACQUIRED FOR  INVESTMENT  AND MAY NOT BE OFFERED FOR SALE,
SOLD,  TRANSFERRED  OR  ASSIGNED  IN THE  ABSENCE OF AN  EFFECTIVE  REGISTRATION
STATEMENT FOR THE SECURITIES  UNDER THE  SECURITIES ACT OF 1933, AS AMENDED,  OR
APPLICABLE  STATE SECURITIES LAWS, OR AN OPINION OF COUNSEL IN A FORM REASONABLY
SATISFACTORY  TO THE ISSUER THAT  REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR
APPLICABLE  STATE SECURITIES LAWS OR UNLESS SOLD PURSUANT TO RULE 144 UNDER SAID
ACT.  NOTWITHSTANDING  THE FOREGOING,  THIS WARRANT MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT.

                                  CIRTRAN CORP.

                        Warrant To Purchase Common Stock

Warrant No.: 2006-001                                Number of Shares: 5,250,000

Date of Issuance: February ___, 2006

CirTran Corp., a Nevada corporation (the "Company"),  hereby certifies that, for
good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, Howard Salamon (the "Holder"), the registered holder hereof or its
permitted  assigns,  is  entitled,  subject  to the terms set  forth  below,  to
purchase from the Company upon  surrender of this Warrant,  at any time or times
on or after  the date  hereof,  but not after  11:59  P.M.  Eastern  Time on the
Expiration  Date (as defined  herein)  Five Million Two Hundred  Fifty  Thousand
(5,250,000)  fully paid and  nonassessable  shares of Common  Stock (as  defined
herein) of the Company (the  "Warrant  Shares") at the exercise  price per share
provided in Section 1(b) below or as subsequently adjusted.

         Section 1.

                  (a) This  Warrant is the common  stock  purchase  warrant (the
"Warrant")  issued pursuant to the Securities  Purchase  Agreement  ("Securities
Purchase  Agreement")  dated the date hereof  between the Company and the Buyers
listed on Schedule I thereto.

                  (b) Definitions. The following words and terms as used in this
Warrant shall have the following meanings:

                           (i)      "Business  Day"  means  any day  other  than
Saturday,  Sunday or other day on which commercial banks in the City of New York
are authorized or required by law to remain closed.

                                       1
<PAGE>

                           (ii)     "Common   Stock"  means  (i)  the  Company's
common stock,  par value $0.001 per share, and (ii) any capital stock into which
such Common Stock shall have been changed or any capital stock  resulting from a
reclassification of such Common Stock.

                           (iii)    "Expiration  Date"  means  the date five (5)
years  from the  Issuance  Date of this  Warrant  or,  if such  date  falls on a
Saturday,  Sunday or other day on which banks are required or  authorized  to be
closed in the City of New York or the State of New York or on which trading does
not take place on the Principal Exchange or automated  quotation system on which
the Common Stock is traded (a "Holiday"), the next date that is not a Holiday.

                           (iv)     "Issuance Date" means the date hereof.

                           (v)      "Person"  means  an  individual,  a  limited
liability  company, a partnership,  a joint venture, a corporation,  a trust, an
unincorporated  organization  and a  government  or  any  department  or  agency
thereof.

                           (vi)     "Principal  Market" means the New York Stock
Exchange,  the American Stock Exchange,  the Nasdaq National Market,  the Nasdaq
SmallCap  Market,  whichever is at the time the  principal  trading  exchange or
market  for such  security,  or the  over-the-counter  market on the  electronic
bulletin  board for such security as reported by Bloomberg or, if no bid or sale
information is reported for such security by Bloomberg,  then the average of the
bid prices of each of the market  makers for such  security  as  reported in the
"pink sheets" by the National Quotation Bureau, Inc.

                           (vii)    "Securities Act" means the Securities Act of
1933, as amended.

                           (viii)   "Warrant"   means  this   Warrant   and  all
Warrants issued in exchange, transfer or replacement thereof.

                           (ix)     "Warrant  Exercise  Price" shall be $0.05 or
as subsequently adjusted as provided in Section 8 hereof.

                           (x)      "Warrant  Shares" means the shares of Common
Stock issuable at any time upon exercise of this Warrant.

                  (c) Other Definitional Provisions.

                           (i)      Except as otherwise  specified  herein,  all
references  herein (A) to the Company  shall be deemed to include the  Company's
successors  and (B) to any applicable law defined or referred to herein shall be
deemed  references  to such  applicable  law as the same may have been or may be
amended or supplemented from time to time.

                           (ii)     When  used  in  this   Warrant,   the  words
"herein",  "hereof", and "hereunder" and words of similar import, shall refer to
this Warrant as a whole and not to any provision of this Warrant,  and the words
"Section",  "Schedule",  and "Exhibit" shall refer to Sections of, and Schedules
and Exhibits to, this Warrant unless otherwise specified.

                                       2
<PAGE>

                           (iii)    Whenever the context so requires, the neuter
gender includes the masculine or feminine,  and the singular number includes the
plural, and vice versa.

         Section 2.  Exercise of Warrant.

                  (a) Subject to the terms and conditions  hereof,  this Warrant
may be  exercised  by the  holder  hereof  then  registered  on the books of the
Company, pro rata as hereinafter provided, at any time on any Business Day on or
after the opening of business on such  Business Day,  commencing  with the first
day  after  the  date  hereof,  and  prior  to 11:59  P.M.  Eastern  Time on the
Expiration  Date  (i) by  delivery  of a  written  notice,  in the  form  of the
subscription  notice  attached as Exhibit A hereto (the "Exercise  Notice"),  of
such holder's election to exercise this Warrant,  which notice shall specify the
number of Warrant  Shares to be  purchased,  payment to the Company of an amount
equal to the Warrant  Exercise  Price(s)  applicable to the Warrant Shares being
purchased, multiplied by the number of Warrant Shares (at the applicable Warrant
Exercise Price) as to which this Warrant is being exercised (plus any applicable
issue or  transfer  taxes)  (the  "Aggregate  Exercise  Price")  in cash or wire
transfer of immediately available funds and the surrender of this Warrant (or an
indemnification  undertaking  with  respect  to this  Warrant in the case of its
loss,  theft or destruction)  to a common carrier for overnight  delivery to the
Company as soon as practicable following such date ("Cash Basis").

         In the event of any exercise of the rights  represented by this Warrant
in  compliance  with this  Section 2, the  Company  shall on or before the fifth
(5th)  Business Day  following the date of receipt of the Exercise  Notice,  the
Aggregate  Exercise  Price and this Warrant (or an  indemnification  undertaking
with respect to this Warrant in the case of its loss,  theft or destruction) and
the receipt of the  representations of the holder specified in Section 6 hereof,
if  requested  by the Company  (the  "Exercise  Delivery  Documents"),  then the
Company shall,  on or before the fifth (5th)  Business Day following  receipt of
the Exercise  Delivery  Documents,  issue and surrender to a common  carrier for
overnight   delivery  to  the  address  specified  in  the  Exercise  Notice,  a
certificate,  registered in the name of the holder,  for the number of shares of
Common  Stock to which the holder  shall be entitled  pursuant to such  request.
Upon delivery of the Exercise  Notice and Aggregate  Exercise  Price referred to
above the holder of this Warrant shall be deemed for all  corporate  purposes to
have  become the holder of record of the Warrant  Shares  with  respect to which
this  Warrant  has  been  exercised.  In  the  case  of  a  dispute  as  to  the
determination of the Warrant Exercise Price or the arithmetic calculation of the
Warrant  Shares,  the Company shall  promptly  issue to the holder the number of
Warrant Shares that is not disputed and shall submit the disputed determinations
or arithmetic  calculations to the holder via facsimile  within one (1) Business
Day of receipt of the holder's Exercise Notice.

                  (b) If the holder and the Company are unable to agree upon the
determination  of the Warrant  Exercise  Price or arithmetic  calculation of the
Warrant Shares within one (1) day of such disputed  determination  or arithmetic
calculation  being submitted to the holder,  then the Company shall  immediately
submit via  facsimile  (i) the disputed  determination  of the Warrant  Exercise
Price to an independent,  reputable investment banking firm or (ii) the disputed
arithmetic  calculation  of  the  Warrant  Shares  to its  independent,  outside
accountant.  The  Company  shall  cause  the  investment  banking  firm  or  the
accountant,  as the case may be, to perform the  determinations  or calculations
and notify the Company  and the holder of the results no later than  forty-eight
(48)  hours  from  the  time  it  receives   the  disputed   determinations   or

                                       3
<PAGE>

calculations.  Such investment  banking firm's or accountant's  determination or
calculation,  as the case may be,  shall be deemed  conclusive  absent  manifest
error.

                  (c) Unless the rights  represented  by this Warrant shall have
expired  or shall have been  fully  exercised,  the  Company  shall,  as soon as
practicable and in no event later than five (5) Business Days after any exercise
and at its own  expense,  issue a new Warrant  identical in all respects to this
Warrant  exercised  except it shall  represent  rights to purchase the number of
Warrant Shares purchasable immediately prior to such exercise under this Warrant
exercised,  less the number of Warrant Shares with respect to which such Warrant
is exercised.

                  (d) No fractional Warrant Shares are to be issued upon any pro
rata  exercise of this Warrant,  but rather the number of Warrant  Shares issued
upon such  exercise of this  Warrant  shall be rounded up or down to the nearest
whole number.

         Section 3.  Covenants as to Common Stock.  The Company hereby covenants
and agrees as follows:

                  (a) This Warrant is, and any Warrants  issued in  substitution
for or  replacement  of this Warrant will upon issuance be, duly  authorized and
validly issued.

                  (b) All Warrant  Shares  which may be issued upon the exercise
of the rights  represented  by this  Warrant  will,  upon  issuance,  be validly
issued,  fully paid and nonassessable and free from all taxes, liens and charges
with respect to the issue thereof.

                  (c) During the period within which the rights  represented  by
this Warrant may be exercised, the Company will at all times have authorized and
reserved at least one hundred  percent  (100%) of the number of shares of Common
Stock needed to provide for the exercise of the rights then  represented by this
Warrant and the par value of said shares will at all times be less than or equal
to the applicable  Warrant  Exercise  Price. If at any time the Company does not
have a sufficient  number of shares of Common Stock  authorized  and  available,
then the  Company  shall  call and hold a special  meeting  of its  stockholders
within  sixty  (60) days of that time for the sole  purpose  of  increasing  the
number of authorized shares of Common Stock.

                  (d) The Company  will not,  by  amendment  of its  Articles of
Incorporation or through any reorganization,  transfer of assets, consolidation,
merger, dissolution, issue or sale of securities, or any other voluntary action,
avoid or seek to avoid the  observance or  performance of any of the terms to be
observed  or  performed  by it  hereunder,  but will at all times in good  faith
assist in the  carrying  out of all the  provisions  of this  Warrant and in the
taking of all such action as may  reasonably  be requested by the holder of this
Warrant in order to protect the exercise privilege of the holder of this Warrant
against dilution or other  impairment,  consistent with the tenor and purpose of
this  Warrant.  The  Company  will not  increase  the par value of any shares of
Common Stock  receivable  upon the  exercise of this  Warrant  above the Warrant
Exercise  Price  then in effect,  and (ii) will take all such  actions as may be
necessary or appropriate in order that the Company may validly and legally issue
fully paid and  nonassessable  shares of Common  Stock upon the exercise of this
Warrant.

                  (e) This Warrant will be binding upon any entity succeeding to
the Company by merger,  consolidation or acquisition of all or substantially all
of the Company's assets.

                                       4
<PAGE>

         Section 4.  Taxes. The Company shall pay any and all taxes,  except any
applicable  withholding,  which may be payable  with respect to the issuance and
delivery of Warrant Shares upon exercise of this Warrant.

         Section 5.  Warrant Holder Not Deemed a Stockholder. Except as
otherwise  specifically  provided  herein,  no holder,  as such, of this Warrant
shall be entitled to vote or receive dividends or be deemed the holder of shares
of capital stock of the Company for any purpose, nor shall anything contained in
this Warrant be construed to confer upon the holder hereof,  as such, any of the
rights of a  stockholder  of the Company or any right to vote,  give or withhold
consent to any corporate  action  (whether any  reorganization,  issue of stock,
reclassification  of stock,  consolidation,  merger,  conveyance or  otherwise),
receive  notice of  meetings,  receive  dividends  or  subscription  rights,  or
otherwise,  prior to the  issuance to the holder of this  Warrant of the Warrant
Shares which he or she is then entitled to receive upon the due exercise of this
Warrant.  In addition,  nothing  contained in this Warrant shall be construed as
imposing  any  liabilities  on such  holder to  purchase  any  securities  (upon
exercise of this  Warrant or  otherwise)  or as a  stockholder  of the  Company,
whether  such  liabilities  are  asserted by the Company or by  creditors of the
Company.  Notwithstanding this Section 5, the Company will provide the holder of
this Warrant with copies of the same notices and other  information given to the
stockholders of the Company generally, contemporaneously with the giving thereof
to the stockholders.

         Section 6.  Representations of Holder.  The holder of this Warrant,  by
the  acceptance  hereof,  represents  that it is acquiring  this Warrant and the
Warrant  Shares  for its own  account  for  investment  only and not with a view
towards,  or for resale in connection  with, the public sale or  distribution of
this  Warrant or the Warrant  Shares,  except  pursuant to sales  registered  or
exempted  under the  Securities  Act;  provided,  however,  that by  making  the
representations herein, the holder does not agree to hold this Warrant or any of
the Warrant Shares for any minimum or other specific term and reserves the right
to dispose of this Warrant and the Warrant Shares at any time in accordance with
or pursuant to a  registration  statement or an exemption  under the  Securities
Act. The holder of this Warrant further represents,  by acceptance hereof, that,
as of this date, such holder is an "accredited investor" as such term is defined
in Rule  501(a)(1) of Regulation D promulgated  by the  Securities  and Exchange
Commission under the Securities Act (an "Accredited Investor"). Upon exercise of
this Warrant, the holder shall, if requested by the Company, confirm in writing,
in a form satisfactory to the Company,  that the Warrant Shares so purchased are
being acquired  solely for the holder's own account and not as a nominee for any
other party, for investment,  and not with a view toward  distribution or resale
and that such holder is an Accredited Investor.  If such holder cannot make such
representations  because  they  would  be  factually  incorrect,  it  shall be a
condition to such  holder's  exercise of this  Warrant that the Company  receive
such other  representations  as the Company  considers  reasonably  necessary to
assure the Company that the  issuance of its  securities  upon  exercise of this
Warrant shall not violate any United States or state securities laws.

         Section 7.  Ownership and Transfer.

                  (a) The  Company  shall  maintain at its  principal  executive
offices (or such other  office or agency of the Company as it may  designate  by
notice to the holder hereof), a register for this Warrant,  in which the Company
shall  record the name and address of the person in whose name this  Warrant has

                                       5
<PAGE>

been issued, as well as the name and address of each transferee. The Company may
treat the person in whose name any Warrant is  registered on the register as the
owner and holder  thereof for all  purposes,  notwithstanding  any notice to the
contrary,  but in all events  recognizing  any transfers made in accordance with
the terms of this Warrant.

         Section 8.  Adjustment of Warrant  Exercise Price and Number of Shares.
The Warrant  Exercise  Price and the number of shares of Common  Stock  issuable
upon exercise of this Warrant shall be adjusted from time to time as follows:

                  (a) Adjustment of Warrant  Exercise Price upon  Subdivision or
Combination  of  Common  Stock.  If the  Company  at any time  after the date of
issuance  of this  Warrant  subdivides  (by any  stock  split,  stock  dividend,
recapitalization  or otherwise) one or more classes of its outstanding shares of
Common  Stock into a greater  number of shares,  any Warrant  Exercise  Price in
effect immediately prior to such subdivision will be proportionately reduced and
the number of shares of Common Stock  obtainable  upon  exercise of this Warrant
will be proportionately  increased. If the Company at any time after the date of
issuance  of this  Warrant  combines  (by  combination,  reverse  stock split or
otherwise) one or more classes of its outstanding  shares of Common Stock into a
smaller number of shares, any Warrant Exercise Price in effect immediately prior
to such combination will be proportionately  increased and the number of Warrant
Shares issuable upon exercise of this Warrant will be proportionately decreased.
Any  adjustment  under this Section 8(a) shall become  effective at the close of
business on the date the subdivision or combination becomes effective.

                  (b) Notice.  Immediately  upon any  adjustment  of the Warrant
Exercise  Price,  the Company will give written  notice thereof to the holder of
this  Warrant,   setting  forth  in  reasonable  detail,  and  certifying,   the
calculation of such adjustment.

         Section 9.  Lost,  Stolen,  Mutilated  or  Destroyed  Warrant.  If this
Warrant is lost, stolen,  mutilated or destroyed, the Company shall promptly, on
receipt  of an  indemnification  undertaking  (or,  in the  case of a  mutilated
Warrant,  the Warrant),  issue a new Warrant of like  denomination  and tenor as
this Warrant so lost, stolen, mutilated or destroyed.

         Section 10. Notice.   Any   notices,    consents,   waivers   or  other
communications required or permitted to be given under the terms of this Warrant
must be in writing and will be deemed to have been delivered:  (i) upon receipt,
when delivered  personally;  (ii) upon receipt, when sent by facsimile (provided
confirmation  of  receipt is  received  by the  sending  party  transmission  is
mechanically or electronically generated and kept on file by the sending party);
or (iii) one Business Day after deposit with a nationally  recognized  overnight
delivery  service,  in each case properly  addressed to the party to receive the
same. The addresses and facsimile numbers for such communications shall be:

                                       6
<PAGE>

If to Holder:                       Howard Salamon
                                    20 Margaret Avenue
                                    Lawrence, New York  11559
                                    Telephone:    516-371-9440
                                    Facsimile:    ____________________________

With Copy to:                       Eric W. Berry
                                    132 Nassau Street, Suite 1310
                                    New York, New York 10038
                                    Telephone:    (212) 355-0777
                                    Facsimile:    (212) 750-1371

If to the Company, to:              CirTran Corp.
                                    4125 S. 6000 West
                                    West Valley City, UT 84128
                                    Attention:    Iehab J. Hawatmeh
                                    Telephone:    (801) 963-5112
                                    Facsimile:    (801) 963-8823

With a copy (which shall            Durham Jones & Pinegar
not constitute notice) to:          111 East Broadway, Suite 900
                                    Salt Lake City, Utah 84111
                                    Attention:    Jeffrey M. Jones, Esq.
                                    Telephone:    (801) 415-3000
                                    Facsimile:    (801) 415-3500

If to a holder of this Warrant,  to it at the address and  facsimile  number set
forth on Exhibit C hereto,  with copies to such holder's  representatives as set
forth on Exhibit C, or at such other address and facsimile as shall be delivered
to the Company upon the issuance or transfer of this  Warrant.  Each party shall
provide  five days'  prior  written  notice to the other  party of any change in
address or facsimile  number.  Written  confirmation of receipt (A) given by the
recipient of such notice, consent, facsimile, waiver or other communication, (or
(B) provided by a nationally  recognized  overnight  delivery  service  shall be
rebuttable evidence of personal service,  receipt by facsimile or receipt from a
nationally  recognized overnight delivery service in accordance with clause (i),
(ii) or (iii) above, respectively.

         Section 11. Date.  The  date of  this  Warrant  is set  forth on page 1
hereof. This Warrant, in all events, shall be wholly void and of no effect after
the close of business on the Expiration Date.

                                       7
<PAGE>

         Section 12. Amendment and Waiver.  Except as otherwise provided herein,
the  provisions  of the  Warrants  may be amended  and the  Company may take any
action  herein  prohibited,  or omit to perform  any act herein  required  to be
performed  by it, only if the Company has  obtained  the written  consent of the
holders of Warrants  representing  at least  two-thirds  of the  Warrant  Shares
issuable upon exercise of the Warrants then  outstanding;  provided that, except
for Section  8(d),  no such action may  increase the Warrant  Exercise  Price or
decrease the number of shares or class of stock  obtainable upon exercise of any
Warrant without the written consent of the holder of such Warrant.

         Section 13. Descriptive  Headings;  Governing   Law.   The  descriptive
headings of the several sections and paragraphs of this Warrant are inserted for
convenience  only and do not  constitute a part of this  Warrant.  The corporate
laws of the State of Nevada  shall  govern all issues  concerning  the  relative
rights of the Company and its stockholders.  All other questions  concerning the
construction,  validity,  enforcement and interpretation of this Agreement shall
be governed by the internal laws of the State of Utah,  without giving effect to
any choice of law or conflict of law  provision or rule (whether of the State of
Utah or any other jurisdictions) that would cause the application of the laws of
any  jurisdictions  other than the State of Utah. Each party hereby  irrevocably
submits to the exclusive jurisdiction of the state and federal courts sitting in
Salt Lake County and the United States  District Court for the District of Utah,
for the  adjudication  of any dispute  hereunder  or in  connection  herewith or
therewith, or with any transaction  contemplated hereby or discussed herein, and
hereby  irrevocably  waives,  and  agrees  not to assert in any suit,  action or
proceeding,  any claim that it is not personally  subject to the jurisdiction of
any  such  court,  that  such  suit,  action  or  proceeding  is  brought  in an
inconvenient  forum or that the  venue of such  suit,  action or  proceeding  is
improper.  Each party hereby  irrevocably waives personal service of process and
consents  to process  being  served in any such suit,  action or  proceeding  by
mailing a copy thereof to such party at the address for such notices to it under
this Agreement and agrees that such service shall constitute good and sufficient
service of process and notice thereof.  Nothing contained herein shall be deemed
to limit in any way any right to serve process in any manner permitted by law.

         Section 14. Waiver of Jury Trial.   AS A MATERIAL  INDUCEMENT  FOR EACH
PARTY HERETO TO ENTER INTO THIS  WARRANT,  THE PARTIES  HERETO  HEREBY WAIVE ANY
RIGHT  TO  TRIAL  BY JURY IN ANY  LEGAL  PROCEEDING  RELATED  IN ANY WAY TO THIS
WARRANT  AND/OR  ANY  AND  ALL OF  THE  OTHER  DOCUMENTS  ASSOCIATED  WITH  THIS
TRANSACTION.

                   REMAINDER OF PAGE INTENTIONALLY LEFT BLANK

                                       8
<PAGE>

         IN WITNESS WHEREOF, the Company has caused this Warrant to be signed as
of the date first set forth above.

                                                   CIRTRAN CORP.

                                                   By:      /s/
                                                      --------------------------
                                                   Name:    Iehab J. Hawatmeh
                                                   Title:   President & CEO

                                       9
<PAGE>

                              EXHIBIT A TO WARRANT
                              --------------------

                                 EXERCISE NOTICE
                                 ---------------

                                 TO BE EXECUTED
                BY THE REGISTERED HOLDER TO EXERCISE THIS WARRANT

                                  CIRTRAN CORP.

         The undersigned holder hereby exercises the right to purchase
______________ of the shares of Common Stock ("Warrant Shares") of Cirtran Corp.
(the "Company"), evidenced by the attached Warrant (the "Warrant"). Capitalized
terms used herein and not otherwise defined shall have the respective meanings
set forth in the Warrant.

         Payment of Warrant  Exercise Price.  The holder shall pay the Aggregate
Exercise Price of $______________ to the Company in accordance with the terms of
the Warrant.

         Delivery of Warrant  Shares.  The Company  shall  deliver to the holder
_________ Warrant Shares in accordance with the terms of the Warrant.

Date:
      -----------------, ------

Name of Registered Holder

By:
   -----------------------------------------
Name:
     ---------------------------------------
Title:
      --------------------------------------

<PAGE>

                              EXHIBIT B TO WARRANT
                              --------------------

                              FORM OF WARRANT POWER
                              ---------------------

         FOR VALUE RECEIVED, the undersigned does hereby assign and transfer to
________________, Federal Identification No. __________, a warrant to purchase
____________ shares of the capital stock of Cirtran Corp. represented by warrant
certificate no. _____, standing in the name of the undersigned on the books of
said corporation. The undersigned does hereby irrevocably constitute and appoint
______________, attorney to transfer the warrants of said corporation, with full
power of substitution in the premises.

Dated:
      -----------------------------              -------------------------------

                                                 By:____________________________
                                                 Name:__________________________
                                                 Title:_________________________

                                       B-1
<PAGE>

                                    EXHIBIT C

<PAGE>

                                     WARRANT
                                     -------

THE SECURITIES  REPRESENTED BY THIS WARRANT HAVE NOT BEEN  REGISTERED  UNDER THE
SECURITIES ACT OF 1933, AS AMENDED,  OR APPLICABLE  STATE  SECURITIES  LAWS. THE
SECURITIES  HAVE BEEN ACQUIRED FOR  INVESTMENT  AND MAY NOT BE OFFERED FOR SALE,
SOLD,  TRANSFERRED  OR  ASSIGNED  IN THE  ABSENCE OF AN  EFFECTIVE  REGISTRATION
STATEMENT FOR THE SECURITIES  UNDER THE  SECURITIES ACT OF 1933, AS AMENDED,  OR
APPLICABLE  STATE SECURITIES LAWS, OR AN OPINION OF COUNSEL IN A FORM REASONABLY
SATISFACTORY  TO THE ISSUER THAT  REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR
APPLICABLE  STATE SECURITIES LAWS OR UNLESS SOLD PURSUANT TO RULE 144 UNDER SAID
ACT.  NOTWITHSTANDING  THE FOREGOING,  THIS WARRANT MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT.

                                  CIRTRAN CORP.

                        Warrant To Purchase Common Stock

Warrant No.: 2006-002                                Number of Shares: 1,750,000

Date of Issuance: February ___, 2006

CirTran Corp., a Nevada corporation (the "Company"),  hereby certifies that, for
good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged,  Melissa A. Cohen (the "Holder"),  the registered holder hereof or
its permitted  assigns,  is entitled,  subject to the terms set forth below,  to
purchase from the Company upon  surrender of this Warrant,  at any time or times
on or after  the date  hereof,  but not after  11:59  P.M.  Eastern  Time on the
Expiration  Date (as defined  herein) One Million Seven  Hundred Fifty  Thousand
(1,750,000)  fully paid and  nonassessable  shares of Common  Stock (as  defined
herein) of the Company (the  "Warrant  Shares") at the exercise  price per share
provided in Section 1(b) below or as subsequently adjusted.

         Section 1.

                  (a) This  Warrant is the common  stock  purchase  warrant (the
"Warrant")  issued pursuant to the Securities  Purchase  Agreement  ("Securities
Purchase  Agreement")  dated the date hereof  between the Company and the Buyers
listed on Schedule I thereto.

                  (b) Definitions. The following words and terms as used in this
Warrant shall have the following meanings:

                           (i)      "Business  Day"  means  any day  other  than
Saturday,  Sunday or other day on which commercial banks in the City of New York
are authorized or required by law to remain closed.

                                       1
<PAGE>

                           (ii)     "Common   Stock"  means  (i)  the  Company's
common stock,  par value $0.001 per share, and (ii) any capital stock into which
such Common Stock shall have been changed or any capital stock  resulting from a
reclassification of such Common Stock.

                           (iii)    "Expiration  Date"  means  the date five (5)
years  from the  Issuance  Date of this  Warrant  or,  if such  date  falls on a
Saturday,  Sunday or other day on which banks are required or  authorized  to be
closed in the City of New York or the State of New York or on which trading does
not take place on the Principal Exchange or automated  quotation system on which
the Common Stock is traded (a "Holiday"), the next date that is not a Holiday.

                           (iv)     "Issuance Date" means the date hereof.

                           (v)      "Person"  means  an  individual,  a  limited
liability  company, a partnership,  a joint venture, a corporation,  a trust, an
unincorporated  organization  and a  government  or  any  department  or  agency
thereof.

                           (vi)     "Principal  Market" means the New York Stock
Exchange,  the American Stock Exchange,  the Nasdaq National Market,  the Nasdaq
SmallCap  Market,  whichever is at the time the  principal  trading  exchange or
market  for such  security,  or the  over-the-counter  market on the  electronic
bulletin  board for such security as reported by Bloomberg or, if no bid or sale
information is reported for such security by Bloomberg,  then the average of the
bid prices of each of the market  makers for such  security  as  reported in the
"pink sheets" by the National Quotation Bureau, Inc.

                           (vii)    "Securities Act" means the Securities Act of
1933, as amended.

                           (viii)   "Warrant"   means  this   Warrant   and  all
Warrants issued in exchange, transfer or replacement thereof.

                           (ix)     "Warrant  Exercise  Price" shall be $0.05 or
as subsequently adjusted as provided in Section 8 hereof.

                           (x)      "Warrant  Shares" means the shares of Common
Stock issuable at any time upon exercise of this Warrant.

                  (c) Other Definitional Provisions.

                           (i)      Except as otherwise  specified  herein,  all
references  herein (A) to the Company  shall be deemed to include the  Company's
successors  and (B) to any applicable law defined or referred to herein shall be
deemed  references  to such  applicable  law as the same may have been or may be
amended or supplemented from time to time.

                           (ii)     When  used  in  this   Warrant,   the  words
"herein",  "hereof", and "hereunder" and words of similar import, shall refer to
this Warrant as a whole and not to any provision of this Warrant,  and the words
"Section",  "Schedule",  and "Exhibit" shall refer to Sections of, and Schedules
and Exhibits to, this Warrant unless otherwise specified.

                                       2
<PAGE>

                           (iii)    Whenever the context so requires, the neuter
gender includes the masculine or feminine,  and the singular number includes the
plural, and vice versa.

         Section 2.  Exercise of Warrant.

                  (a) Subject to the terms and conditions  hereof,  this Warrant
may be  exercised  by the  holder  hereof  then  registered  on the books of the
Company, pro rata as hereinafter provided, at any time on any Business Day on or
after the opening of business on such  Business Day,  commencing  with the first
day  after  the  date  hereof,  and  prior  to 11:59  P.M.  Eastern  Time on the
Expiration  Date  (i) by  delivery  of a  written  notice,  in the  form  of the
subscription  notice  attached as Exhibit A hereto (the "Exercise  Notice"),  of
such holder's election to exercise this Warrant,  which notice shall specify the
number of Warrant  Shares to be  purchased,  payment to the Company of an amount
equal to the Warrant  Exercise  Price(s)  applicable to the Warrant Shares being
purchased, multiplied by the number of Warrant Shares (at the applicable Warrant
Exercise Price) as to which this Warrant is being exercised (plus any applicable
issue or  transfer  taxes)  (the  "Aggregate  Exercise  Price")  in cash or wire
transfer of immediately available funds and the surrender of this Warrant (or an
indemnification  undertaking  with  respect  to this  Warrant in the case of its
loss,  theft or destruction)  to a common carrier for overnight  delivery to the
Company as soon as practicable following such date ("Cash Basis").

         In the event of any exercise of the rights  represented by this Warrant
in  compliance  with this  Section 2, the  Company  shall on or before the fifth
(5th)  Business Day  following the date of receipt of the Exercise  Notice,  the
Aggregate  Exercise  Price and this Warrant (or an  indemnification  undertaking
with respect to this Warrant in the case of its loss,  theft or destruction) and
the receipt of the  representations of the holder specified in Section 6 hereof,
if  requested  by the Company  (the  "Exercise  Delivery  Documents"),  then the
Company shall,  on or before the fifth (5th)  Business Day following  receipt of
the Exercise  Delivery  Documents,  issue and surrender to a common  carrier for
overnight   delivery  to  the  address  specified  in  the  Exercise  Notice,  a
certificate,  registered in the name of the holder,  for the number of shares of
Common  Stock to which the holder  shall be entitled  pursuant to such  request.
Upon delivery of the Exercise  Notice and Aggregate  Exercise  Price referred to
above the holder of this Warrant shall be deemed for all  corporate  purposes to
have  become the holder of record of the Warrant  Shares  with  respect to which
this  Warrant  has  been  exercised.  In  the  case  of  a  dispute  as  to  the
determination of the Warrant Exercise Price or the arithmetic calculation of the
Warrant  Shares,  the Company shall  promptly  issue to the holder the number of
Warrant Shares that is not disputed and shall submit the disputed determinations
or arithmetic  calculations to the holder via facsimile  within one (1) Business
Day of receipt of the holder's Exercise Notice.

                  (b) If the holder and the Company are unable to agree upon the
determination  of the Warrant  Exercise  Price or arithmetic  calculation of the
Warrant Shares within one (1) day of such disputed  determination  or arithmetic
calculation  being submitted to the holder,  then the Company shall  immediately
submit via  facsimile  (i) the disputed  determination  of the Warrant  Exercise
Price to an independent,  reputable investment banking firm or (ii) the disputed
arithmetic  calculation  of  the  Warrant  Shares  to its  independent,  outside
accountant.  The  Company  shall  cause  the  investment  banking  firm  or  the
accountant,  as the case may be, to perform the  determinations  or calculations
and notify the Company  and the holder of the results no later than  forty-eight
(48)  hours  from  the  time  it  receives   the  disputed   determinations   or

                                       3
<PAGE>

calculations.  Such investment  banking firm's or accountant's  determination or
calculation,  as the case may be,  shall be deemed  conclusive  absent  manifest
error.

                  (c) Unless the rights  represented  by this Warrant shall have
expired  or shall have been  fully  exercised,  the  Company  shall,  as soon as
practicable and in no event later than five (5) Business Days after any exercise
and at its own  expense,  issue a new Warrant  identical in all respects to this
Warrant  exercised  except it shall  represent  rights to purchase the number of
Warrant Shares purchasable immediately prior to such exercise under this Warrant
exercised,  less the number of Warrant Shares with respect to which such Warrant
is exercised.

                  (d) No fractional Warrant Shares are to be issued upon any pro
rata  exercise of this Warrant,  but rather the number of Warrant  Shares issued
upon such  exercise of this  Warrant  shall be rounded up or down to the nearest
whole number.

         Section 3.  Covenants as to Common Stock. The Company hereby  covenants
and agrees as follows:

                  (a) This Warrant is, and any Warrants  issued in  substitution
for or  replacement  of this Warrant will upon issuance be, duly  authorized and
validly issued.

                  (b) All Warrant  Shares  which may be issued upon the exercise
of the rights  represented  by this  Warrant  will,  upon  issuance,  be validly
issued,  fully paid and nonassessable and free from all taxes, liens and charges
with respect to the issue thereof.

                  (c) During the period within which the rights  represented  by
this Warrant may be exercised, the Company will at all times have authorized and
reserved at least one hundred  percent  (100%) of the number of shares of Common
Stock needed to provide for the exercise of the rights then  represented by this
Warrant and the par value of said shares will at all times be less than or equal
to the applicable  Warrant  Exercise  Price. If at any time the Company does not
have a sufficient  number of shares of Common Stock  authorized  and  available,
then the  Company  shall  call and hold a special  meeting  of its  stockholders
within  sixty  (60) days of that time for the sole  purpose  of  increasing  the
number of authorized shares of Common Stock.

                  (d) The Company  will not,  by  amendment  of its  Articles of
Incorporation or through any reorganization,  transfer of assets, consolidation,
merger, dissolution, issue or sale of securities, or any other voluntary action,
avoid or seek to avoid the  observance or  performance of any of the terms to be
observed  or  performed  by it  hereunder,  but will at all times in good  faith
assist in the  carrying  out of all the  provisions  of this  Warrant and in the
taking of all such action as may  reasonably  be requested by the holder of this
Warrant in order to protect the exercise privilege of the holder of this Warrant
against dilution or other  impairment,  consistent with the tenor and purpose of
this  Warrant.  The  Company  will not  increase  the par value of any shares of
Common Stock  receivable  upon the  exercise of this  Warrant  above the Warrant
Exercise  Price  then in effect,  and (ii) will take all such  actions as may be
necessary or appropriate in order that the Company may validly and legally issue
fully paid and  nonassessable  shares of Common  Stock upon the exercise of this
Warrant.

                  (e) This Warrant will be binding upon any entity succeeding to
the Company by merger,  consolidation or acquisition of all or substantially all
of the Company's assets.

                                       4
<PAGE>

         Section 4.  Taxes.  The Company shall pay any and all taxes, except any
applicable  withholding,  which may be payable  with respect to the issuance and
delivery of Warrant Shares upon exercise of this Warrant.

         Section 5.  Warrant  Holder   Not   Deemed  a  Stockholder.  Except  as
otherwise  specifically  provided  herein,  no holder,  as such, of this Warrant
shall be entitled to vote or receive dividends or be deemed the holder of shares
of capital stock of the Company for any purpose, nor shall anything contained in
this Warrant be construed to confer upon the holder hereof,  as such, any of the
rights of a  stockholder  of the Company or any right to vote,  give or withhold
consent to any corporate  action  (whether any  reorganization,  issue of stock,
reclassification  of stock,  consolidation,  merger,  conveyance or  otherwise),
receive  notice of  meetings,  receive  dividends  or  subscription  rights,  or
otherwise,  prior to the  issuance to the holder of this  Warrant of the Warrant
Shares which he or she is then entitled to receive upon the due exercise of this
Warrant.  In addition,  nothing  contained in this Warrant shall be construed as
imposing  any  liabilities  on such  holder to  purchase  any  securities  (upon
exercise of this  Warrant or  otherwise)  or as a  stockholder  of the  Company,
whether  such  liabilities  are  asserted by the Company or by  creditors of the
Company.  Notwithstanding this Section 5, the Company will provide the holder of
this Warrant with copies of the same notices and other  information given to the
stockholders of the Company generally, contemporaneously with the giving thereof
to the stockholders.

         Section 6.  Representations of Holder.  The holder of this Warrant,  by
the  acceptance  hereof,  represents  that it is acquiring  this Warrant and the
Warrant  Shares  for its own  account  for  investment  only and not with a view
towards,  or for resale in connection  with, the public sale or  distribution of
this  Warrant or the Warrant  Shares,  except  pursuant to sales  registered  or
exempted  under the  Securities  Act;  provided,  however,  that by  making  the
representations herein, the holder does not agree to hold this Warrant or any of
the Warrant Shares for any minimum or other specific term and reserves the right
to dispose of this Warrant and the Warrant Shares at any time in accordance with
or pursuant to a  registration  statement or an exemption  under the  Securities
Act. The holder of this Warrant further represents,  by acceptance hereof, that,
as of this date, such holder is an "accredited investor" as such term is defined
in Rule  501(a)(1) of Regulation D promulgated  by the  Securities  and Exchange
Commission under the Securities Act (an "Accredited Investor"). Upon exercise of
this Warrant, the holder shall, if requested by the Company, confirm in writing,
in a form satisfactory to the Company,  that the Warrant Shares so purchased are
being acquired  solely for the holder's own account and not as a nominee for any
other party, for investment,  and not with a view toward  distribution or resale
and that such holder is an Accredited Investor.  If such holder cannot make such
representations  because  they  would  be  factually  incorrect,  it  shall be a
condition to such  holder's  exercise of this  Warrant that the Company  receive
such other  representations  as the Company  considers  reasonably  necessary to
assure the Company that the  issuance of its  securities  upon  exercise of this
Warrant shall not violate any United States or state securities laws.

         Section 7.  Ownership and Transfer.

                  (a) The  Company  shall  maintain at its  principal  executive
offices (or such other  office or agency of the Company as it may  designate  by
notice to the holder hereof), a register for this Warrant,  in which the Company
shall  record the name and address of the person in whose name this  Warrant has

                                       5
<PAGE>

been issued, as well as the name and address of each transferee. The Company may
treat the person in whose name any Warrant is  registered on the register as the
owner and holder  thereof for all  purposes,  notwithstanding  any notice to the
contrary,  but in all events  recognizing  any transfers made in accordance with
the terms of this Warrant.

         Section 8.  Adjustment of Warrant  Exercise Price and Number of Shares.
The Warrant  Exercise  Price and the number of shares of Common  Stock  issuable
upon exercise of this Warrant shall be adjusted from time to time as follows:

                  (a) Adjustment of Warrant  Exercise Price upon  Subdivision or
Combination  of  Common  Stock.  If the  Company  at any time  after the date of
issuance  of this  Warrant  subdivides  (by any  stock  split,  stock  dividend,
recapitalization  or otherwise) one or more classes of its outstanding shares of
Common  Stock into a greater  number of shares,  any Warrant  Exercise  Price in
effect immediately prior to such subdivision will be proportionately reduced and
the number of shares of Common Stock  obtainable  upon  exercise of this Warrant
will be proportionately  increased. If the Company at any time after the date of
issuance  of this  Warrant  combines  (by  combination,  reverse  stock split or
otherwise) one or more classes of its outstanding  shares of Common Stock into a
smaller number of shares, any Warrant Exercise Price in effect immediately prior
to such combination will be proportionately  increased and the number of Warrant
Shares issuable upon exercise of this Warrant will be proportionately decreased.
Any  adjustment  under this Section 8(a) shall become  effective at the close of
business on the date the subdivision or combination becomes effective.

                  (b) Notice.  Immediately  upon any  adjustment  of the Warrant
Exercise  Price,  the Company will give written  notice thereof to the holder of
this  Warrant,   setting  forth  in  reasonable  detail,  and  certifying,   the
calculation of such adjustment.

         Section  9. Lost,  Stolen,  Mutilated  or  Destroyed  Warrant.  If this
Warrant is lost, stolen,  mutilated or destroyed, the Company shall promptly, on
receipt  of an  indemnification  undertaking  (or,  in the  case of a  mutilated
Warrant,  the Warrant),  issue a new Warrant of like  denomination  and tenor as
this Warrant so lost, stolen, mutilated or destroyed.

         Section 10. Notice.   Any   notices,   consents,   waivers   or   other
communications required or permitted to be given under the terms of this Warrant
must be in writing and will be deemed to have been delivered:  (i) upon receipt,
when delivered  personally;  (ii) upon receipt, when sent by facsimile (provided
confirmation  of  receipt is  received  by the  sending  party  transmission  is
mechanically or electronically generated and kept on file by the sending party);
or (iii) one Business Day after deposit with a nationally  recognized  overnight
delivery  service,  in each case properly  addressed to the party to receive the
same. The addresses and facsimile numbers for such communications shall be:

                                       6
<PAGE>

If to Holder:                       Melissa A. Cohen
                                    222 West 83rd Street
                                    New York, New York   10024
                                    Telephone:    (212) 721-5781
                                    Facsimile:    (212) 608-2913

With Copy to:                       Eric W. Berry
                                    132 Nassau Street, Suite 1310
                                    New York, New York 10038
                                    Telephone:    (212) 355-0777
                                    Facsimile:    (212) 750-1371

If to the Company, to:              CirTran Corp.
                                    4125 S. 6000 West
                                    West Valley City, UT 84128
                                    Attention:    Iehab J. Hawatmeh
                                    Telephone:    (801) 963-5112
                                    Facsimile:    (801) 963-8823

With a copy (which shall            Durham Jones & Pinegar
not constitute notice) to:          111 East Broadway, Suite 900
                                    Salt Lake City, Utah 84111
                                    Attention:    Jeffrey M. Jones, Esq.
                                    Telephone:    (801) 415-3000
                                    Facsimile:    (801) 415-3500

If to a holder of this Warrant,  to it at the address and  facsimile  number set
forth on Exhibit C hereto,  with copies to such holder's  representatives as set
forth on Exhibit C, or at such other address and facsimile as shall be delivered
to the Company upon the issuance or transfer of this  Warrant.  Each party shall
provide  five days'  prior  written  notice to the other  party of any change in
address or facsimile  number.  Written  confirmation of receipt (A) given by the
recipient of such notice, consent, facsimile, waiver or other communication, (or
(B) provided by a nationally  recognized  overnight  delivery  service  shall be
rebuttable evidence of personal service,  receipt by facsimile or receipt from a
nationally  recognized overnight delivery service in accordance with clause (i),
(ii) or (iii) above, respectively.

         Section 11. Date.  The  date of  this  Warrant  is set  forth on page 1
hereof. This Warrant, in all events, shall be wholly void and of no effect after
the close of business on the Expiration Date.

                                       7
<PAGE>

         Section 12. Amendment and Waiver.  Except as otherwise provided herein,
the  provisions  of the  Warrants  may be amended  and the  Company may take any
action  herein  prohibited,  or omit to perform  any act herein  required  to be
performed  by it, only if the Company has  obtained  the written  consent of the
holders of Warrants  representing  at least  two-thirds  of the  Warrant  Shares
issuable upon exercise of the Warrants then  outstanding;  provided that, except
for Section  8(d),  no such action may  increase the Warrant  Exercise  Price or
decrease the number of shares or class of stock  obtainable upon exercise of any
Warrant without the written consent of the holder of such Warrant.

         Section 13. Descriptive  Headings;  Governing   Law.  The   descriptive
headings of the several sections and paragraphs of this Warrant are inserted for
convenience  only and do not  constitute a part of this  Warrant.  The corporate
laws of the State of Nevada  shall  govern all issues  concerning  the  relative
rights of the Company and its stockholders.  All other questions  concerning the
construction,  validity,  enforcement and interpretation of this Agreement shall
be governed by the internal laws of the State of Utah,  without giving effect to
any choice of law or conflict of law  provision or rule (whether of the State of
Utah or any other jurisdictions) that would cause the application of the laws of
any  jurisdictions  other than the State of Utah. Each party hereby  irrevocably
submits to the exclusive jurisdiction of the state and federal courts sitting in
Salt Lake County and the United States  District Court for the District of Utah,
for the  adjudication  of any dispute  hereunder  or in  connection  herewith or
therewith, or with any transaction  contemplated hereby or discussed herein, and
hereby  irrevocably  waives,  and  agrees  not to assert in any suit,  action or
proceeding,  any claim that it is not personally  subject to the jurisdiction of
any  such  court,  that  such  suit,  action  or  proceeding  is  brought  in an
inconvenient  forum or that the  venue of such  suit,  action or  proceeding  is
improper.  Each party hereby  irrevocably waives personal service of process and
consents  to process  being  served in any such suit,  action or  proceeding  by
mailing a copy thereof to such party at the address for such notices to it under
this Agreement and agrees that such service shall constitute good and sufficient
service of process and notice thereof.  Nothing contained herein shall be deemed
to limit in any way any right to serve process in any manner permitted by law.

         Section 14. Waiver of Jury Trial.   AS A MATERIAL  INDUCEMENT  FOR EACH
PARTY HERETO TO ENTER INTO THIS  WARRANT,  THE PARTIES  HERETO  HEREBY WAIVE ANY
RIGHT  TO  TRIAL  BY JURY IN ANY  LEGAL  PROCEEDING  RELATED  IN ANY WAY TO THIS
WARRANT  AND/OR  ANY  AND  ALL OF  THE  OTHER  DOCUMENTS  ASSOCIATED  WITH  THIS
TRANSACTION.

                   REMAINDER OF PAGE INTENTIONALLY LEFT BLANK

                                       8
<PAGE>

         IN WITNESS WHEREOF, the Company has caused this Warrant to be signed as
of the date first set forth above.

                                                  CIRTRAN CORP.

                                                  By:      /s/
                                                     ---------------------------
                                                  Name:    Iehab J. Hawatmeh
                                                  Title:   President & CEO

                                       9
<PAGE>

                              EXHIBIT A TO WARRANT
                              --------------------

                                 EXERCISE NOTICE
                                 ---------------

                                 TO BE EXECUTED
                BY THE REGISTERED HOLDER TO EXERCISE THIS WARRANT

                                  CIRTRAN CORP.

         The  undersigned   holder  hereby   exercises  the  right  to  purchase
______________ of the shares of Common Stock ("Warrant Shares") of Cirtran Corp.
(the "Company"), evidenced by the attached Warrant (the "Warrant").  Capitalized
terms used herein and not otherwise  defined shall have the respective  meanings
set forth in the Warrant.

         Payment of Warrant  Exercise Price.  The holder shall pay the Aggregate
Exercise Price of $______________ to the Company in accordance with the terms of
the Warrant.

         Delivery of Warrant  Shares.  The Company  shall  deliver to the holder
_________ Warrant Shares in accordance with the terms of the Warrant.

Date:
      ------------------, ------

Name of Registered Holder

By:
   -----------------------------------------
Name:
     ---------------------------------------
Title:
      --------------------------------------

<PAGE>

                              EXHIBIT B TO WARRANT
                              --------------------

                              FORM OF WARRANT POWER
                              ---------------------

         FOR VALUE RECEIVED,  the undersigned does hereby assign and transfer to
________________,  Federal Identification No. __________,  a warrant to purchase
____________ shares of the capital stock of Cirtran Corp. represented by warrant
certificate  no. _____,  standing in the name of the undersigned on the books of
said corporation. The undersigned does hereby irrevocably constitute and appoint
______________, attorney to transfer the warrants of said corporation, with full
power of substitution in the premises.

Dated:
      -------------------------------        -----------------------------------

                                             By:________________________________
                                             Name:______________________________
                                             Title:_____________________________

                                       B-1
<PAGE>

                                    EXHIBIT D

<PAGE>

DURHAM JONES & PINEGAR
David L. Arrington (4267)
David W. Tufts (8736)
Chad J. Pomeroy (9224)
111 East Broadway, Suite 900
P.O. Box 4050
Salt Lake City, Utah 84110-4050
(801) 415-3000

Attorneys for Defendant

PARR WADDOUPS BROWN GEE & LOVELESS
Robert B. Lochhead
185 South State Street, Suite 1300
Salt Lake City, Utah  84111

Attorneys for Plaintiff

                       IN THE UNITED STATES DISTRICT COURT
                       DISTRICT OF UTAH, CENTRAL DIVISION

--------------------------------------------------------------------------------
                                        |
HOWARD SALAMON d/b/a SALAMON BROTHERS,  |         REQUEST FOR DISMISSAL
                                        |
         Plaintiff,                     |
                                        |        Case No. 2:03CV00787 TS
         vs.                            |
                                        |          Honorable Ted Stewart
CIRTRAN CORP.,                          |
                                        |
         Defendant.                     |
                                        |
--------------------------------------------------------------------------------

                                       1
<PAGE>

         IT IS HEREBY STIPULATED by and between plaintiff Howard Salamon d/b/a

Salamon Brothers and defendant CirTran Corporation that plaintiff's Complaint

and Supplemental Complaint in this action be dismissed with prejudice, pursuant

to Rule 41(a)(2), Federal Rules of Civil Procedure, each party to bear its own

attorneys' fees and costs.

Dated:  February ___, 2006          DURHAM JONES & PINEGAR

                                    --------------------------------
                                    David W. Tufts

                                    Attorneys for defendant

Dated:  February ___, 2006          PARR WADDOUPS BROWN GEE & LOVELESS

                                    --------------------------------
                                    Robert B. Lochhead

                                    Attorneys for plaintiff

                                       2
<PAGE>

DURHAM JONES & PINEGAR
David L. Arrington (4267)
David W. Tufts (8736)
Chad J. Pomeroy (9224)
111 East Broadway, Suite 900
P.O. Box 4050
Salt Lake City, Utah 84110-4050
 (801) 415-3000

Attorneys for Defendant

PARR WADDOUPS BROWN GEE & LOVELESS
Robert B. Lochhead
185 South State Street, Suite 1300
Salt Lake City, Utah  84111

Attorneys for Plaintiff

                       IN THE UNITED STATES DISTRICT COURT
                       DISTRICT OF UTAH, CENTRAL DIVISION

--------------------------------------------------------------------------------
                                       |
HOWARD SALAMON d/b/a SALAMON BROTHERS, |           ORDER OF DISMISSAL
                                       |
         Plaintiff,                    |
                                       |         Case No. 2:03CV00787 TS
         vs.                           |
                                       |          Honorable Ted Stewart
CIRTRAN CORP.,                         |
                                       |
         Defendant.                    |
                                       |
--------------------------------------------------------------------------------

                                       1
<PAGE>

         BASED ON THE STIPULATION by and between plaintiff Howard Salamon d/b/a

Salamon Brothers and defendant CirTran Corporation, it is ordered that

plaintiff's Complaint and Supplemental Complaint in this action be, and hereby

are, dismissed with prejudice, pursuant to Rule 41(a)(2), Federal Rules of Civil

Procedure, each party to bear its own attorneys' fees and costs.

         Dated:  ______________

                                  BY THE COURT:

                                  -----------------------------------------
                                  Judge Ted Stewart
                                  United States District Court, District of Utah

                                       2

--------------------------------------------------------------------------------

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00105-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00105-of-00352.parquet"}]]